These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17642240)
21. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study. Genovese MC; Kaine JL; Lowenstein MB; Del Giudice J; Baldassare A; Schechtman J; Fudman E; Kohen M; Gujrathi S; Trapp RG; Sweiss NJ; Spaniolo G; Dummer W; Arthritis Rheum; 2008 Sep; 58(9):2652-61. PubMed ID: 18759293 [TBL] [Abstract][Full Text] [Related]
22. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [TBL] [Abstract][Full Text] [Related]
23. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510 [TBL] [Abstract][Full Text] [Related]
24. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [TBL] [Abstract][Full Text] [Related]
25. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Brown SL; Greene MH; Gershon SK; Edwards ET; Braun MM Arthritis Rheum; 2002 Dec; 46(12):3151-8. PubMed ID: 12483718 [TBL] [Abstract][Full Text] [Related]
27. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624 [TBL] [Abstract][Full Text] [Related]
28. [Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response]. Yamamura M Nihon Rinsho; 2007 Jul; 65(7):1269-75. PubMed ID: 17642242 [TBL] [Abstract][Full Text] [Related]
29. [Clinical experience with infliximab administration in patients with rheumatoid arthritis (according to Russian register data)]. Lukina GV; Sigidin IaA; Nasonov EL Ter Arkh; 2009; 81(8):65-9. PubMed ID: 19799204 [TBL] [Abstract][Full Text] [Related]
30. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912 [TBL] [Abstract][Full Text] [Related]
31. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration. Toki H; Momohara S; Tsukahara S; Ikari K J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300 [No Abstract] [Full Text] [Related]